QuickView for COP9 signalosome (biogroup)

1. Neural development of iPSCs derived from Autistic patients with BCKD-kinase mutations
2. PBMC microRNA expression from pulmonary tuberculosis and sarcoidosis patients
3. miRNA expression In maintenance and differentiation of human embryonic stem cells
4. Lung adenocarcinoma and adjacent normal tissue miRNA expression profiles
5. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)

1. Purification of the COP9 signalosome complex and binding partners from human T cells.
2. Altered expression of COP9 signalosome proteins in preeclampsia.
3. CDK inhibitor p57 (Kip2) is negatively regulated by COP9 signalosome subunit 6.
4. Roles of COP9 signalosome in cancer.
5. Control of NF-kappaB activation by the COP9 signalosome.

There were no clinical trials for COP9 signalosome